Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, crossover trial

Journal of Pediatrics

Volumn 130, Issue 2, 1997, Pages 266-273

  McCrindle, B W ^a   O'Neill, M B ^a   Cullen Dean, G ^a   Helden, E ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COLESTYRAMINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; ORAL DRUG ADMINISTRATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PILL; POWDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030722513     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(97)70353-6     Document Type: Article

References (25)

1. GN Levine JF Keaney JA. Vita Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms N Engl J Med 332 1995 512 521
2. WC. Roberts Preventing and arresting coronary atherosclerosis Am Heart J 130 1995 580 600
3. WP Newman III DS Freedman AW Voors Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa Heart Study N Engl J Med 314 1986 138 144
4. PDAY Research Group Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking JAMA 264 1990 3018 3024
5. KB Schwarz PD Goldstein JL Witztum G. Schonfeld Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol Pediatrics 65 1980 243 250
6. CJ Glueck RC Tsang RW Fallat D. Scheel Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin Pediatrics 54 1974 51 55
7. BM. Rifkind Lipid Research Clinics Coronary Primary Prevention Trial: results and implications Am J Cardiol 54 1984 30C 34C
8. RJ West JK. Lloyd Use of cholestyramine in treatment of children with familial hypercholesterolaemia Arch Dis Child 48 1973 370 374
9. CJ Glueck R Fallat R. Tsang Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin Pediatrics 52 1973 669 679
10. CJ Glueck RW Fallat M Mellies RC. Tsang Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin Pediatrics 57 1976 68 74
11. CJ Glueck RC Tsang RW Fallat M. Mellies Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months Pediatrics 59 1977 433 441
12. RJ West JK. Lloyd Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine Lancet 2 1980 873 875
13. PHE Groot R Dijhuis-Stoffelsma WFA Grose JJ Ambagtsheer J. Fernandes The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia Acta Paediatr Scand 72 1983 81 85
14. CA Liacouras PM Coates PR Gallagher JA. Cortner Use of cholestyrramine in the treatment of children with familial combined hyperlipidemia J Pediatr 122 1993 477 482
15. American Academy of Pediatrics National Cholesterol Education Program: report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents Pediatrics 89 1992 525 584
16. SL Rosenthal S Knauer-Black MP Stahl TJ Catalanotto DL. Sprecher The psychological functioning of children with hypercholesterolemia and their families: a preliminary investigation Clin Pediatr 32 1993 135 141
17. L Ose S. Tonstad The detection and management of dyslipidemia in children and adolescents Acta Paediatr 84 1995 1213 1215
18. D Hansen KF Michaelsen F. Skovby Growth during treatment of familial hypercholesterolemia Acta Paediatr 81 1992 1023 1025
19. G Oster AM. Epstein Cost-effectiveness of antihyperlipidemic therapy in the prevention of coronary heart disease: the case of cholestyramine JAMA 258 1987 2381 2387
20. W Insull NR Marquis MC. Tsianco Comparison of the efficacy of Questran Light, a new formulation of cholestyramine powder, to regular Questran in maintaining lowered plasma cholesterol levels Am J Cardiol 67 1991 501 505
21. JR Farah PO Kwiterovich CA. Neill Dose-effect relation of cholestyramine in children and young adults with familial hypercholesterolaemia Lancet 1 1977 59 63
22. CK. Tebbi Treatment compliance in childhood and adolescence Cancer 71 Suppl 1993 3441 3449
23. CA Dujovne SB Chernoff P Krehbiel B Jackson S DeCoursey H. Taylor Low-dose colestipol plus probucol for hypercholesterolemia Am J Cardiol 53 1984 1514 1518
24. HG Schrott EA Stein CA Dujovne Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy Am J Cardiol 75 1995 34 39
25. DL Sprecher J Abrams JW Allen Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients Ann Intern Med 120 1994 537 543